vanadates has been researched along with Nerve Degeneration in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (33.33) | 2.80 |
| Authors | Studies |
|---|---|
| Adejare, A; Dybek, MB; Elufioye, TO; Folarin, OR; Ladagu, AD; Olopade, FE; Olopade, JO; Wallach, JV | 1 |
| Dankowski, A; Hagg, T; Yang, P | 1 |
| Camandola, S; Mattson, MP; Poli, G | 1 |
3 other study(ies) available for vanadates and Nerve Degeneration
| Article | Year |
|---|---|
Novel NMDA-receptor antagonists ameliorate vanadium neurotoxicity.
Topics: Animals; Astrocytes; Calbindins; Cell Death; Disease Models, Animal; Excitatory Amino Acid Antagonists; Glial Fibrillary Acidic Protein; Mice; Microglia; Nerve Degeneration; Neurotoxicity Syndromes; Purkinje Cells; Receptors, N-Methyl-D-Aspartate; Vanadates | 2020 |
Protein tyrosine phosphatase inhibition reduces degeneration of dopaminergic substantia nigra neurons and projections in 6-OHDA treated adult rats.
Topics: Animals; Brain-Derived Neurotrophic Factor; Dopamine; Dose-Response Relationship, Drug; Enzyme Inhibitors; Female; Gene Expression; Nerve Degeneration; Nerve Growth Factors; Neurons; Oxidopamine; Phosphorylation; Protein Tyrosine Phosphatases; Rats; Rats, Sprague-Dawley; Stilbamidines; Substantia Nigra; Tyrosine 3-Monooxygenase; Vanadates | 2007 |
The lipid peroxidation product 4-hydroxy-2,3-nonenal inhibits constitutive and inducible activity of nuclear factor kappa B in neurons.
Topics: Aldehydes; Alzheimer Disease; Animals; Apoptosis; Cell Survival; Cells, Cultured; Cerebral Cortex; Cycloheximide; Cysteine Proteinase Inhibitors; Enzyme Inhibitors; Lipid Peroxidation; Nerve Degeneration; Neurons; NF-kappa B; Okadaic Acid; Protein Synthesis Inhibitors; Rats; Stroke; Transcription Factor AP-1; Vanadates | 2000 |